Safety and efficacy of Magnesium Sulfate in the management of Tetanus: A systematic review. Issue 10 (2nd September 2021)

• Record Type: Journal Article
• Authors: Nepal, Gaurav; Coghlan, Megan Ariel; Yadav, Jayant Kumar; Kharel, Sanjeev; Ka Shing, Yow; Ojha, Rajeev; Xing, Hou Shuang; Bo, Yu; Zhi Lan, Tu
• Is Part Of: Tropical medicine & international health. Volume 26:Issue 10(2021)
• Page Start: 1200
• Page End: 1209
• Publication Date: 2021-09-02
• Subjects: magnesium -- magnesium sulphate -- MgSO4 -- Tetanus; Tropical medicine -- Periodicals; Public health -- Periodicals; 616.988
• DOI: 10.1111/tmi.13667
• Languages: English
• ISSNs: 1360-2276

Abstract

Summary: Tetanus is a rare life‐threatening condition often complicated by repetitive spasms, dysautonomia and neuromuscular respiratory failure contributing to high fatality rates in its severe form. Benzodiazepines used to treat muscle spasms pose a high risk of respiratory failure requiring mechanical ventilation, which is unaffordable and inaccessible for many. Magnesium sulfate, a cheap and widely available medication in all urban and rural health centres of LMICs for the treatment of eclampsia, can be used to control muscle spasms and dysautonomia. We thus conducted a systematic review of evidence to assess the safety and efficacy of magnesium sulfate in the treatment of tetanus. Any study published before April 15, 2021, discussing the efficacy and/or safety of MgSO4 infusion in the treatment of tetanus was systemically reviewed using the Preferred Reporting Items for Systematic Reviews and Meta‐Analyses (PRISMA). Our systematic review included data from 13 studies, three were randomised, double‐blind and controlled trials. The remaining ten studies were observational; six prospective and four retrospective studies. Our review showed no mortality benefit associated with the use of magnesium sulfate. However, magnesium sulfate was found to be effective in reducing spasms along with diazepam, leading to better control of dysautonomia, reduced need for mechanical ventilation and shorter hospital stay by 3–7 days. The incidence of magnesium toxicity was very low in the studies included.